SCHEMBL4528040

SCHEMBL4528040

CC(=O)Nc1nc(C)c(C(C)=O)o1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.41
KDM4E B2RXH2 5/20 0.41
LMNA P02545 2/20 0.41
NR4A2 P43354 1/20 0.41
HSD17B10 Q99714 3/20 0.38
PIK3CG P48736 2/20 0.35
RAB9A P51151 1/20 0.34
HPGD P15428 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
POLB P06746 2/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4510023 0.81 ALDH1A1 (0.37) ALDH1A1KDM4ELMNANR4A2HSD17B10
SCHEMBL16176214 0.80 ALDH1A1 (0.49) ALDH1A1KDM4ELMNAHSD17B10RAB9A
SCHEMBL16437815 0.71 SMN1; SMN2 (0.37) ALDH1A1KDM4ELMNAHSD17B10HPGD
SCHEMBL5960474 0.69 SMN1; SMN2 (0.35) ALDH1A1KDM4ELMNAHSD17B10HPGD
SCHEMBL4528112 0.69 HSD17B10 (0.37) ALDH1A1KDM4ELMNAHSD17B10HPGD
SCHEMBL15868809 0.67 ALDH1A1 (0.35) ALDH1A1KDM4ELMNANR4A2HPGD
SCHEMBL8616898 0.67 DDR1 (0.40) KDM4EHSD17B10SMN1; SMN2MAPT
SCHEMBL19628643 0.67 PIK3CG (0.35) ALDH1A1KDM4ELMNAHSD17B10PIK3CG
SCHEMBL12222705 0.65 EPHX2 (0.49) ALDH1A1KDM4ELMNANR4A2RAB9A
SCHEMBL22308291 0.64 ALDH1A1 (0.49) ALDH1A1KDM4ELMNAHSD17B10RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108863972-B Oxazole amide derivative and preparation method and application thereof 湖南大学 2020-08-04 CN disclosed
US-9150561-B2 Thiazole derivatives and use thereof MERCK SERONO S.A. (CH) 2015-10-06 US disclosed
US-20140228365-A1 THIAZOLE DERIVATIVES AND USE THEREOF MERCK SERONO S.A. (CH) 2014-08-14 US disclosed
US-8802861-B2 Thiazole derivatives and use thereof MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-20090029998-A1 Thiazole Derivatives and Use Thereof APPLIED RESEARCH SYSTEM ARS HOLDING N.V. (NL) 2009-01-29 US disclosed
EP-1709019-B1 THIAZOLE DERIVATIVES AND USE THEREOF APPLIED RESEARCH SYSTEMS (AN) 2007-08-08 EP disclosed
EP-1709019-A2 THIAZOLE DERIVATIVES AND USE THEREOF Applied Research Systems ARS Holding N.V. (AN) 2006-10-11 EP disclosed
WO-2005068444-A2 THIAZOLE DERIVATIVES AND USE THEREOF APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-07-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140228365-A1 THIAZOLE DERIVATIVES AND USE THEREOF PF4, TEC, PDGFRB ALDH1A1 234/4885KDM4E 4820/4885LMNA 4675/4885
US-20090029998-A1 Thiazole Derivatives and Use Thereof PDGFRB, PDGFRA, TEC ALDH1A1 174/4885KDM4E 4801/4885LMNA 4765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.